Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - Emmaus Life Sciences, Inc. | ea141356-8k_emmauslife.htm |
Exhibit 99.1
 | ||
Baker Tilly US, LLP 3655 Nobel Dr; Ste 300 San Diego, CA 92122
F: +1 (858) 597 4111
|
May 19, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Emmaus Life Sciences, Inc., which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 304(a)(1) of Regulation S-K, as part of Item 4.01 of Form 8-K of Emmaus Life Sciences, Inc. dated May 19, 2021. We agree with the statements concerning our Firm contained therein.
Very truly yours.
/s/ Baker Tilly US, LLP
San Diego, California
Baker Tilly US, LLP, trading as Baker Tilly, is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. © 2020 Baker Tilly US, LLP